Athena Countouriotis Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Athena Countouriotis.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Athena Countouriotis. Athena Countouriotis is SVP and Chief Medical Officer in HALOZYME THERAPEUTICS INC ($GYHT) and Chief Medical Officer in AMBIT BIOSCIENCES CORP ($AMBI) and Director in Trovagene, Inc. ($XNOM.OB) and Director in IOVANCE BIOTHERAPEUTICS, INC. ($IOVA) and SVP, Chief Medical Officer in Adverum Biotechnologies, Inc. ($ADVM) and President & CEO in Turning Point Therapeutics, Inc. ($TPTX) and Director in Passage BIO, Inc. ($PASG).

Latest Insider Trading Transactions of Athena Countouriotis

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ADVM, AMBI, XNOM.OB, GYHT, IOVA, PASG, TPTX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 11 2021TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOOption ExerciseM3.208,94228,614173,389
Feb 11 2021TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOOption ExerciseM3.2025,39281,254182,331
Feb 11 2021TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOOption ExerciseM3.207,66624,53167,575
Feb 11 2021TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOOption ExerciseM3.2018,00057,600207,723
Feb 11 2021TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOSellS138.553,052422,85550,19553.2 K to 50.2 K (-5.73 %)
Feb 11 2021TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOSellS137.661,571216,26453,24754.8 K to 53.2 K (-2.87 %)
Feb 11 2021TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOSellS136.454,319589,32854,81859.1 K to 54.8 K (-7.30 %)
Feb 11 2021TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOBuyM3.208,94228,61459,13750.2 K to 59.1 K (+17.81 %)
Feb 11 2021TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOSellS138.1943359,83650,19550.6 K to 50.2 K (-0.86 %)
Feb 11 2021TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOSellS137.462,081286,05450,62852.7 K to 50.6 K (-3.95 %)
Feb 11 2021TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOSellS136.4216,6262,268,11952,70969.3 K to 52.7 K (-23.98 %)
Feb 11 2021TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOSellS135.725,227709,40869,33574.6 K to 69.3 K (-7.01 %)
Feb 11 2021TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOSellS134.341,025137,69974,56275.6 K to 74.6 K (-1.36 %)
Feb 11 2021TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOBuyM3.2025,39281,25475,58750.2 K to 75.6 K (+50.59 %)
Feb 11 2021TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOSellS140.241,104154,82550,19551.3 K to 50.2 K (-2.15 %)
Feb 11 2021TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOSellS139.6913,2901,856,48051,29964.6 K to 51.3 K (-20.58 %)
Feb 11 2021TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOSellS138.664,969689,00264,58969.6 K to 64.6 K (-7.14 %)
Feb 11 2021TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOSellS137.5810314,17169,55869.7 K to 69.6 K (-0.15 %)
Feb 11 2021TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOSellS136.296,200844,99869,66175.9 K to 69.7 K (-8.17 %)
Feb 11 2021TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOBuyM3.207,66624,53175,86168.2 K to 75.9 K (+11.24 %)
Feb 11 2021TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOBuyM3.2018,00057,60068,19550.2 K to 68.2 K (+35.86 %)
Feb 10 2021TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOOption ExerciseA140.01101,77514,249,518101,775
Feb 10 2021TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOGrantA0.0022,617050,19527.6 K to 50.2 K (+82.01 %)
Jun 10 2020IOVAIOVANCE BIOTHERAPE ...Countouriotis AthenaDirectorOption ExerciseA32.1735,0001,125,95035,000
May 26 2020TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOBuyP60.004,166249,96026,87222.7 K to 26.9 K (+18.35 %)
Mar 25 2020PASGPassage BIO, Inc.Countouriotis AthenaDirectorBuyP14.9810,000149,75018,9008.9 K to 18.9 K (+112.36 %)
Mar 25 2020PASGPassage BIO, Inc.Countouriotis AthenaDirectorBuyP14.9810,000149,75018,9008.9 K to 18.9 K (+112.36 %)
Mar 02 2020PASGPassage BIO, Inc.Countouriotis AthenaDirectorOption ExerciseA18.0033,836609,04833,836
Jan 08 2020TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOOption ExerciseA63.33325,00020,582,250325,000
Jan 08 2020TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOGrantA31.1370621,97622,70622 K to 22.7 K (+3.21 %)
Sep 11 2019TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOBuyP45.0010,000450,00022,00012 K to 22 K (+83.33 %)
Jun 24 2019XNOM.OBTrovagene, Inc.Countouriotis AthenaDirectorOption ExerciseA2.4844,734110,94046,019
Jun 11 2019IOVAIOVANCE BIOTHERAPE ...Countouriotis AthenaDirectorOption ExerciseA19.9335,000697,55035,000
Apr 24 2019TPTXTurning Point Ther ...Countouriotis AthenaPresident & CEOBuyP18.0012,000216,00012,0000 to 12 K
Feb 20 2018ADVMAdverum Biotechnol ...Countouriotis AthenaSVP, Chief Medical ...Option ExerciseA6.40160,0001,024,000160,000
Jan 25 2018XNOM.OBTrovagene, Inc.Countouriotis AthenaDirectorOption ExerciseA0.3054,32216,29792,428
Jun 21 2017ADVMAdverum Biotechnol ...Countouriotis AthenaSVP, Chief Medical ...Option ExerciseA2.90213,000617,700213,000
Jun 21 2017ADVMAdverum Biotechnol ...Countouriotis AthenaSVP, Chief Medical ...GrantA0.00150,0000150,0000 to 150 K
Feb 06 2017GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...Option ExerciseM0.0018,496055,487
Feb 06 2017GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...Payment of ExerciseF12.266,90084,59439,07746 K to 39.1 K (-15.01 %)
Feb 06 2017GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...BuyM0.0018,496045,97727.5 K to 46 K (+67.30 %)
Jan 09 2017GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...Option ExerciseM0.007,500015,000
Jan 09 2017GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...BuyM0.007,500027,48120 K to 27.5 K (+37.54 %)
Jul 05 2016GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...Option ExerciseM0.006,45000
Jul 05 2016GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...Option ExerciseA0.006,45006,450
Jul 05 2016GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...Payment of ExerciseF8.6310792319,98120.1 K to 20 K (-0.53 %)
Jul 05 2016GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...BuyM0.006,450020,08813.6 K to 20.1 K (+47.29 %)
Feb 04 2016GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...Option ExerciseA0.0073,983073,983
Feb 04 2016GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...Option ExerciseA8.11125,5231,017,992125,523
Jan 07 2016GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...Option ExerciseM0.007,500022,500
Jan 07 2016GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...Payment of ExerciseF16.393,25753,38213,63816.9 K to 13.6 K (-19.28 %)
Jan 07 2016GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...BuyM0.007,500016,8959.4 K to 16.9 K (+79.83 %)
Jan 04 2016GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...Payment of ExerciseF17.335,65598,0019,39515.1 K to 9.4 K (-37.57 %)
Jan 04 2016GYHTHALOZYME THERAPEUT ...Countouriotis AthenaSVP and Chief Medic ...GrantA0.0015,050015,0500 to 15.1 K
Nov 12 2014AMBIAMBIT BIOSCIENCES ...Countouriotis AthenaChief Medical Offic ...Option ExerciseD0.0018,88200
Nov 12 2014AMBIAMBIT BIOSCIENCES ...Countouriotis AthenaChief Medical Offic ...Option ExerciseD10.8045,000486,0000
Nov 12 2014AMBIAMBIT BIOSCIENCES ...Countouriotis AthenaChief Medical Offic ...Option ExerciseD11.8176,481903,2410
Nov 12 2014AMBIAMBIT BIOSCIENCES ...Countouriotis AthenaChief Medical Offic ...Option ExerciseD6.00100,645603,8700
May 19 2014AMBIAMBIT BIOSCIENCES ...Countouriotis AthenaChief Medical Offic ...Option ExerciseA0.0018,882018,882
Jan 10 2014AMBIAMBIT BIOSCIENCES ...Countouriotis AthenaChief Medical Offic ...Option ExerciseA10.8045,000486,00045,000
Jul 18 2013AMBIAMBIT BIOSCIENCES ...Countouriotis AthenaChief Medical Offic ...Option ExerciseA11.8176,481903,24176,481

Page:   1

Contact us | Follow us on Twitter